June Business and People Slideshow
Business and people highlights from our June issue, including four recent hires and a new facility in the UK.
James Dixon
Bringing with him more than 25 years in the pharmaceutical, biotechnology, and CRO industries, James Dixon has been named Senior Vice President, Quality and Compliance at Cetero Research (Cary, NC).
Richard Farris
Novella Clinical (Research Triangle Park, NC) has made several changes to its team including the appointment of Richard Farris as Senior Director for Project Management and the promotion of Michael Doyle to Global Head of Regulatory Affairs.
Robin Sutherland
Quanticate (Cambridge, MA) has appointed Robin Sutherland as Head of US Operations where she will be responsible for all aspects of business expansion across the United States and Canada.
Dawn Duggan
Dawn Duggan has joined A10 Clinical Solutions (Cary, NC) as Director of Strategic Clinical Solutions where she will be responsible for strategically growing A10’s presence within the northeastern US pharmaceutical and biotechnology hub.
Dr. Reddy’s Laboratories
Pictured above: Y. Hamied, PhD, Chairman of Cipla and Honorary Fellow of Christ’s College, Cambridge, and G. V. Prasad, Vice Chairman and CEO.
Dr. Reddy’s Laboratories has opened a newly expanded Chirotech Technology Center at Cambridge Science Park, UK where Chirotech has been based for the last 20 years. The new 33,000 sq ft facility is purpose built for laboratories and offices and has been fitted to Dr. Reddy’s specific requirements for chemistry, biology and analytics.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
